Please ensure Javascript is enabled for purposes of website accessibility

Why Investors Are Looking Past Steve Jobs

By Tim Beyers – Updated Apr 6, 2017 at 1:47AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

They see Apple succeeding no matter what.

Over the weekend, The Wall Street Journal revealed that Apple (NASDAQ:AAPL) Chief Executive Steve Jobs went to Tennessee to get a liver transplant while on medical leave. Investors don't seem to care. That's what the math tells me.

Shares of Apple were down roughly 1% in early trading today, well short of the 5% haircut six months ago when Jobs handed the reins to Chief Operating Officer Tim Cook amid speculative reports that he was considering -- wait for it -- a liver transplant.

If investors aren't as worried this time, it could be because a healthier Jobs is on track to return to Apple by the end of June, an Apple representative told the Journal. Even so, the newspaper cites a source who says Jobs' doctors may encourage him to work part-time for at least a couple of months.

So be it. As the Journal story was breaking, Piper Jaffray's Gene Munster was counting sales of the new iPhone 3G S. In his research, released this morning, he predicts that Apple and partner AT&T (NYSE:T) sold 750,000 handsets over the weekend, far more than his original projection of a half-million.

Turns out the typically optimistic Munster was lowballing it: Apple said in a press release this morning that it had sold more than 1 million handsets, exceeding last year's record launch and making Palm's (NASDAQ:PALM) strong opening for the new Pre smartphone look weak by comparison.

Research In Motion (NASDAQ:RIMM), meanwhile, faces a tough task battling enthusiasm for the 3G S. Munster's research estimates that 12% of those who bought the new iPhone switched from the BlackBerry, Fortune reports.

Who needs Jobs with numbers like that?

Apple is better off with Jobs than without him, of course. I'm among many who are relieved that he's recovering. But if the hoo-ha over Jobs' health problems says anything, it should be that Apple is a more attractive investment today than it was six months ago. That Apple was the Cult of Steve. Today's Apple is the Cult of Mac, iPhone, and the i-Yet-to-Be-Created.

What's more, going by 3G S sales data, Apple's diversified brain trust -- a structure more like Steve Ballmer's Microsoft (NASDAQ:MSFT) than Michael Dell's Dell (NASDAQ:DELL) -- shares Jobs' penchant for exceeding expectations.

Investors don't care about the Journal report because they've already seen the post-Jobs era, and it doesn't look all that different.

Get your clicks with related Foolishness:

Apple is a Stock Advisor selection. Dell and Microsoft are Inside Value picks. Try any of our Foolish newsletter services free for 30 days.

Fool contributor Tim Beyers had stock and options positions in Apple at the time of publication. Check out Tim's portfolio holdings and Foolish writings, or connect with him on Twitter as @milehighfool. The Motley Fool is also on Twitter as @TheMotleyFool. The Fool's disclosure policy is taking its trading guidelines in for an oil change.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Apple Inc. Stock Quote
Apple Inc.
AAPL
$150.77 (0.23%) $0.34
Microsoft Corporation Stock Quote
Microsoft Corporation
MSFT
$237.45 (-0.20%) $0.47
AT&T Inc. Stock Quote
AT&T Inc.
T
$15.67 (-2.12%) $0.34
Dell Technologies Inc. Stock Quote
Dell Technologies Inc.
DELL.DL
BlackBerry Stock Quote
BlackBerry
BB
$4.97 (-1.97%) $0.10
Palm, Inc. Stock Quote
Palm, Inc.
PALM

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.